Key facts
- Megadata’s last known valuation is $10.0M (Jun 2023).
- It has raised $970K; the latest was Later Stage VC in Mar 2025.
- Notable investors include Avidbank Holdings, Blossom Street Ventures, Blueprint Equity, Channel Equity Partners.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Megadata
- ·The full record, as it builds
Funding rounds
No funding rounds for Megadata are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Megadata
Developer of a SaaS-based business intelligence platform designed to help healthcare organizations improve patient care. The company's platform offers various tools, such as clinical, billing, labor, purchasing, financial, and many more, enabling healthcare organizations to identify trends and patterns in patient data, which can be used to improve clinical decision-making.
- Sector
- Healthcare
- HQ
- Lakewood, NJ, United States
- Founded
- 2017
- Employees
- 33
- Website
- getmegadata.com/
- Ownership
- Privately Held (backing)
Megadata doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Megadata shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Megadata in its N-PORT filings yet. We sweep new filings monthly.